HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Arnold S Monto Selected Research

Influenza Vaccines (Influenza Vaccine)

3/2022Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness - United States, February 2022.
1/2022Role of Age in the Spread of Influenza, 2011-2019: Data From the US Influenza Vaccine Effectiveness Network.
1/2022Vaccine Effectiveness Against Acute Respiratory Illness Hospitalizations for Influenza-Associated Pneumonia During the 2015-2016 to 2017-2018 Seasons: US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).
10/2021Effectiveness of Influenza Vaccines in the HIVE Household Cohort Over 8 Years: Is There Evidence of Indirect Protection?
1/2021Influenza Vaccine Effectiveness Against Hospitalization in the United States, 2019-2020.
1/2021Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines Against Influenza B in the United States, 2011-2012 to 2016-2017.
1/2021Vaccine Effectiveness Against Influenza-Associated Hospitalizations Among Adults, 2018-2019, US Hospitalized Adult Influenza Vaccine Effectiveness Network.
1/2021Home collection of nasal swabs for detection of influenza in the Household Influenza Vaccine Evaluation Study.
1/2021Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses.
1/2021Waning Vaccine Effectiveness Against Influenza-Associated Hospitalizations Among Adults, 2015-2016 to 2018-2019, United States Hospitalized Adult Influenza Vaccine Effectiveness Network.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Arnold S Monto Research Topics

Disease

119Human Influenza (Influenza)
11/2022 - 03/2002
40Infections
05/2022 - 03/2002
18COVID-19
10/2022 - 01/2020
4Pneumonia (Pneumonitis)
01/2022 - 11/2006
3Disease Progression
10/2022 - 01/2018
3Respiratory Tract Infections (Respiratory Tract Infection)
01/2020 - 02/2003
2Severe Acute Respiratory Syndrome
01/2021 - 09/2006
2Frailty
01/2019 - 01/2019
2Asthma (Bronchial Asthma)
01/2018 - 10/2012
2Fever (Fevers)
01/2018 - 09/2006
2Otitis Media
01/2018 - 11/2006
2Cough
05/2016 - 09/2006
1Respiratory Insufficiency (Respiratory Failure)
03/2022
1Reinfection
01/2021
1Drug-Related Side Effects and Adverse Reactions
12/2020
1Sinusitis
01/2018
1Pharyngitis (Sore Throat)
01/2018
1Bronchitis
01/2018
1Pregnancy Complications
01/2017
1Nausea
05/2015
1Vomiting
05/2015
1Herpesviridae Infections (Herpesvirus Infection)
02/2014
1Virus Diseases (Viral Diseases)
12/2013
1Vaccine-Preventable Diseases
07/2013
1Hepatitis A (Hepatitis, Infectious)
10/2007
1Anthrax
09/2006
1Communicable Diseases (Infectious Diseases)
09/2006
1Acquired Immunodeficiency Syndrome (AIDS)
02/2003

Drug/Important Bio-Agent (IBA)

90VaccinesIBA
10/2022 - 04/2005
58Influenza Vaccines (Influenza Vaccine)FDA Link
03/2022 - 08/2004
25Antiviral Agents (Antivirals)IBA
11/2022 - 02/2003
13Oseltamivir (Tamiflu)FDA Link
01/2018 - 08/2004
11mRNA VaccinesIBA
10/2022 - 07/2021
11AntibodiesIBA
01/2022 - 09/2010
11Neuraminidase (Sialidase)IBA
05/2019 - 03/2002
8Hemagglutinins (Hemagglutinin)IBA
01/2022 - 09/2010
7COVID-19 VaccinesIBA
10/2022 - 05/2021
7Inactivated VaccinesIBA
01/2021 - 12/2006
7Attenuated VaccinesIBA
10/2017 - 12/2006
6RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2022 - 01/2013
5AntigensIBA
10/2017 - 08/2004
5Zanamivir (Relenza)FDA Link
01/2007 - 12/2002
4Pharmaceutical PreparationsIBA
11/2022 - 10/2008
4Messenger RNA (mRNA)IBA
02/2022 - 11/2021
4Anti-Bacterial Agents (Antibiotics)IBA
12/2020 - 11/2006
3BNT162 VaccineIBA
03/2022 - 11/2021
22019-nCoV Vaccine mRNA-1273IBA
03/2022 - 01/2022
2EpitopesIBA
01/2022 - 01/2018
2Biological ProductsIBA
01/2017 - 12/2013
2EnzymesIBA
09/2006 - 07/2006
1Ad26COVS1IBA
10/2022
1Nucleic AcidsIBA
11/2021
1Immunoglobulin G (IgG)IBA
09/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1Combined VaccinesIBA
01/2021
1Immunoglobulin M (IgM)IBA
01/2020
1CI 22IBA
01/2019
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2019
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
01/2018
1cyclo(Arg-Pro) (CI 4)IBA
10/2016
1Surface Antigens (Surface Antigen)IBA
12/2015
1peramivirIBA
12/2014
1Indicators and Reagents (Reagents)IBA
09/2010
1LigandsIBA
09/2010
1Immunoglobulins (Immunoglobulin)IBA
10/2007
1Hepatitis A Vaccines (Hepatitis A Vaccine)IBA
10/2007
14-O-carboxymethylascochlorinIBA
11/2006
1Amantadine (Aman)FDA LinkGeneric
11/2003
1Prescription DrugsIBA
02/2003

Therapy/Procedure

5Therapeutics
09/2014 - 03/2002
3Ambulatory Care (Outpatient Care)
12/2020 - 09/2014
3Hand Hygiene
07/2012 - 02/2010
2Artificial Respiration (Mechanical Ventilation)
10/2022 - 11/2021
2Home Nursing (Nursing, Home)
11/2006 - 08/2004
1Critical Care (Surgical Intensive Care)
01/2022
1Mechanical Ventilators (Ventilator)
12/2021
1Length of Stay
12/2021
1Medical Day Care (Partial Hospitalization)
10/2007
1Patient Isolation
09/2006